{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:31:58Z","timestamp":1791664318623,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AOA Theta Chapter at Albany Medical College"},{"DOI":"10.13039\/100020066","name":"Feldstein Medical Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020066","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Center for Advancing Translational Sciences of the National Institutes of Health","award":["UL1TR002384"],"award-info":[{"award-number":["UL1TR002384"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autologous blood-derived products such as platelet-rich plasma (PRP) are widely used to treat musculoskeletal conditions, including knee osteoarthritis (OA). However, the clinical outcomes after PRP administration are often variable, and there is limited information about the specific characteristics of PRP that impact bioactivity and clinical responses. In this study, we aimed to develop an integrative workflow to evaluate responses to PRP in vitro, and to assess if the in vitro responses to PRP are associated with the PRP composition and clinical outcomes in patients with knee OA. To do this, we used a coculture system of macrophages and fibroblasts paired with transcriptomic analyses to comprehensively characterize the modulation of inflammatory responses by PRP in vitro. Relying on patient-reported outcomes and achievement of minimal clinically important differences in OA patients receiving PRP injections, we identified responders and non-responders to the treatment. Comparisons of PRP from these patient groups allowed us to identify differences in the composition and in vitro activity of PRP. We believe that our integrative workflow may enable the development of targeted approaches that rely on PRP and other orthobiologics to treat musculoskeletal pathologies.<\/jats:p>","DOI":"10.1038\/s41598-021-90174-x","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T15:20:18Z","timestamp":1622560818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["In vitro responses to platelet-rich-plasma are associated with variable clinical outcomes in patients with knee osteoarthritis"],"prefix":"10.1038","volume":"11","author":[{"given":"Habib","family":"Zahir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurii","family":"Chinenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Burge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyna","family":"Bandhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nemirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Moley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollis","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Donlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Ivashkiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Rodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"90174_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41584-019-0221-y","volume":"15","author":"PG Conaghan","year":"2019","unstructured":"Conaghan, P. G., Cook, A. D., Hamilton, J. A. & Tak, P. P. Therapeutic options for targeting inflammatory osteoarthritis pain. Nat. Rev. Rheumatol. 15, 355\u2013363. https:\/\/doi.org\/10.1038\/s41584-019-0221-y (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"90174_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/BOR.0b013e328349c2b1","volume":"23","author":"MB Goldring","year":"2011","unstructured":"Goldring, M. B. & Otero, M. Inflammation in osteoarthritis. Curr. Opin. Rheumatol. 23, 471\u2013478. https:\/\/doi.org\/10.1097\/BOR.0b013e328349c2b1 (2011).","journal-title":"Curr. Opin. Rheumatol."},{"key":"90174_CR3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s12178-019-09578-y","volume":"12","author":"B Dehghani","year":"2019","unstructured":"Dehghani, B. & Rodeo, S. Cell therapy-a basic science primer for the sports medicine clinician. Curr. Rev. Musculoskelet. Med. 12, 436\u2013445. https:\/\/doi.org\/10.1007\/s12178-019-09578-y (2019).","journal-title":"Curr. Rev. Musculoskelet. Med."},{"key":"90174_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrrheum.2013.141","volume":"9","author":"I Andia","year":"2013","unstructured":"Andia, I. & Maffulli, N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat. Rev. Rheumatol. 9, 721\u2013730. https:\/\/doi.org\/10.1038\/nrrheum.2013.141 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"90174_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.arthro.2009.11.015","volume":"26","author":"E Lopez-Vidriero","year":"2010","unstructured":"Lopez-Vidriero, E., Goulding, K. A., Simon, D. A., Sanchez, M. & Johnson, D. H. The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy 26, 269\u2013278. https:\/\/doi.org\/10.1016\/j.arthro.2009.11.015 (2010).","journal-title":"Arthroscopy"},{"key":"90174_CR6","doi-asserted-by":"publisher","first-page":"43301","DOI":"10.1038\/srep43301","volume":"7","author":"Z Xu","year":"2017","unstructured":"Xu, Z. et al. Comparative evaluation of leukocyte- and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration. Sci. Rep. 7, 43301. https:\/\/doi.org\/10.1038\/srep43301 (2017).","journal-title":"Sci. Rep."},{"key":"90174_CR7","doi-asserted-by":"publisher","first-page":"19449","DOI":"10.1038\/s41598-020-76466-8","volume":"10","author":"A Barlian","year":"2020","unstructured":"Barlian, A., Judawisastra, H., Ridwan, A., Wahyuni, A. R. & Lingga, M. E. Chondrogenic differentiation of Wharton\u2019s Jelly mesenchymal stem cells on silk spidroin-fibroin mix scaffold supplemented with L-ascorbic acid and platelet rich plasma. Sci. Rep. 10, 19449. https:\/\/doi.org\/10.1038\/s41598-020-76466-8 (2020).","journal-title":"Sci. Rep."},{"key":"90174_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00264-016-3342-9","volume":"41","author":"A Roffi","year":"2017","unstructured":"Roffi, A., Di Matteo, B., Krishnakumar, G. S., Kon, E. & Filardo, G. Platelet-rich plasma for the treatment of bone defects: from pre-clinical rational to evidence in the clinical practice. A systematic review. Int. Orthop. 41, 221\u2013237. https:\/\/doi.org\/10.1007\/s00264-016-3342-9 (2017).","journal-title":"Int. Orthop."},{"key":"90174_CR9","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1038\/s41598-020-63496-5","volume":"10","author":"N Yin","year":"2020","unstructured":"Yin, N. et al. Platelet-rich plasma enhances the repair capacity of muscle-derived mesenchymal stem cells to large humeral bone defect in rabbits. Sci. Rep. 10, 6771. https:\/\/doi.org\/10.1038\/s41598-020-63496-5 (2020).","journal-title":"Sci. Rep."},{"key":"90174_CR10","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1007\/s00167-016-4261-4","volume":"26","author":"G Filardo","year":"2018","unstructured":"Filardo, G., Di Matteo, B., Kon, E., Merli, G. & Marcacci, M. Platelet-rich plasma in tendon-related disorders: results and indications. Knee Surg. Sports Traumatol. Arthrosc. 26, 1984\u20131999. https:\/\/doi.org\/10.1007\/s00167-016-4261-4 (2018).","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"90174_CR11","doi-asserted-by":"publisher","first-page":"204173141882003","DOI":"10.1177\/2041731418820034","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Selectively activated PRP exerts differential effects on tendon stem\/progenitor cells and tendon healing. J. Tissue Eng. 10, 2041731418820034. https:\/\/doi.org\/10.1177\/2041731418820034 (2019).","journal-title":"J. Tissue Eng."},{"key":"90174_CR12","doi-asserted-by":"publisher","first-page":"3204869","DOI":"10.1155\/2018\/3204869","volume":"2018","author":"M Koch","year":"2018","unstructured":"Koch, M. et al. Partial anterior cruciate ligament ruptures: advantages by intraligament autologous conditioned plasma injection and healing response technique-midterm outcome evaluation. Biomed. Res. Int. 2018, 3204869. https:\/\/doi.org\/10.1155\/2018\/3204869 (2018).","journal-title":"Biomed. Res. Int."},{"key":"90174_CR13","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1002\/jor.23599","volume":"35","author":"AM Krismer","year":"2017","unstructured":"Krismer, A. M. et al. Biologic response of human anterior cruciate ligamentocytes on collagen-patches to platelet-rich plasma formulations with and without leucocytes. J. Orthop. Res. 35, 2733\u20132739. https:\/\/doi.org\/10.1002\/jor.23599 (2017).","journal-title":"J. Orthop. Res."},{"key":"90174_CR14","doi-asserted-by":"publisher","first-page":"204062231982556","DOI":"10.1177\/2040622319825567","volume":"10","author":"L Gato-Calvo","year":"2019","unstructured":"Gato-Calvo, L., Magalhaes, J., Ruiz-Romero, C., Blanco, F. J. & Burguera, E. F. Platelet-rich plasma in osteoarthritis treatment: review of current evidence. Ther. Adv. Chronic Dis. 10, 2040622319825567. https:\/\/doi.org\/10.1177\/2040622319825567 (2019).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"90174_CR15","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.5435\/JAAOS-D-18-00305","volume":"27","author":"CR Chu","year":"2019","unstructured":"Chu, C. R. et al. Optimizing clinical use of biologics in orthopaedic surgery: consensus recommendations from the 2018 AAOS\/NIH U-13 conference. J. Am. Acad. Orthop. Surg. 27, e50\u2013e63. https:\/\/doi.org\/10.5435\/JAAOS-D-18-00305 (2019).","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"90174_CR16","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.4049\/jimmunol.1400486","volume":"193","author":"LT Donlin","year":"2014","unstructured":"Donlin, L. T., Jayatilleke, A., Giannopoulou, E. G., Kalliolias, G. D. & Ivashkiv, L. B. Modulation of TNF-induced macrophage polarization by synovial fibroblasts. J. Immunol. 193, 2373\u20132383. https:\/\/doi.org\/10.4049\/jimmunol.1400486 (2014).","journal-title":"J. Immunol."},{"issue":"Suppl 120","key":"90174_CR17","first-page":"57","volume":"37","author":"TM Griffin","year":"2019","unstructured":"Griffin, T. M. & Scanzello, C. R. Innate inflammation and synovial macrophages in osteoarthritis pathophysiology. Clin. Exp. Rheumatol. 37(Suppl 120), 57\u201363 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"90174_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s41927-019-0093-4","volume":"3","author":"TW Kragstrup","year":"2019","unstructured":"Kragstrup, T. W. et al. Fibroblast-like synovial cell production of extra domain A fibronectin associates with inflammation in osteoarthritis. BMC Rheumatol. 3, 46. https:\/\/doi.org\/10.1186\/s41927-019-0093-4 (2019).","journal-title":"BMC Rheumatol."},{"key":"90174_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar, J. T., Young, J. P. Jr., LaMoreaux, L., Werth, J. L. & Poole, R. M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94, 149\u2013158. https:\/\/doi.org\/10.1016\/s0304-3959(01)00349-9 (2001).","journal-title":"Pain"},{"key":"90174_CR20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s11999-016-4719-1","volume":"474","author":"S Lyman","year":"2016","unstructured":"Lyman, S. et al. Validation of the KOOS, JR: a short-form knee arthroplasty outcomes survey. Clin. Orthop. Relat. Res. 474, 1461\u20131471. https:\/\/doi.org\/10.1007\/s11999-016-4719-1 (2016).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"90174_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5312\/wjo.v9.i3.41","volume":"9","author":"M Hung","year":"2018","unstructured":"Hung, M., Bounsanga, J., Voss, M. W. & Saltzman, C. L. Establishing minimum clinically important difference values for the patient-reported outcomes measurement information system physical function, hip disability and osteoarthritis outcome score for joint reconstruction, and knee injury and osteoarthritis outcome score for joint reconstruction in orthopaedics. World J. Orthop. 9, 41\u201349. https:\/\/doi.org\/10.5312\/wjo.v9.i3.41 (2018).","journal-title":"World J. Orthop."},{"key":"90174_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejpain.2003.09.004","volume":"8","author":"F Salaffi","year":"2004","unstructured":"Salaffi, F., Stancati, A., Silvestri, C. A., Ciapetti, A. & Grassi, W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur. J. Pain 8, 283\u2013291. https:\/\/doi.org\/10.1016\/j.ejpain.2003.09.004 (2004).","journal-title":"Eur. J. Pain"},{"key":"90174_CR23","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00590-020-02623-4","volume":"30","author":"E Hohmann","year":"2020","unstructured":"Hohmann, E., Tetsworth, K. & Glatt, V. Is platelet-rich plasma effective for the treatment of knee osteoarthritis? A systematic review and meta-analysis of level 1 and 2 randomized controlled trials. Eur. J. Orthop. Surg. Traumatol. 30, 955\u2013967. https:\/\/doi.org\/10.1007\/s00590-020-02623-4 (2020).","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"90174_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2106\/JBJS.16.00793","volume":"99","author":"IR Murray","year":"2017","unstructured":"Murray, I. R., Geeslin, A. G., Goudie, E. B., Petrigliano, F. A. & LaPrade, R. F. Minimum information for studies evaluating biologics in orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J. Bone Joint Surg. Am. 99, 809\u2013819. https:\/\/doi.org\/10.2106\/JBJS.16.00793 (2017).","journal-title":"J. Bone Joint Surg. Am."},{"key":"90174_CR25","doi-asserted-by":"publisher","first-page":"6591717","DOI":"10.1155\/2016\/6591717","volume":"2016","author":"C Cavallo","year":"2016","unstructured":"Cavallo, C. et al. Platelet-rich plasma: the choice of activation method affects the release of bioactive molecules. Biomed. Res. Int. 2016, 6591717. https:\/\/doi.org\/10.1155\/2016\/6591717 (2016).","journal-title":"Biomed. Res. Int."},{"key":"90174_CR26","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/art.37853","volume":"65","author":"A Lee","year":"2013","unstructured":"Lee, A. et al. Tumor necrosis factor alpha induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 65, 928\u2013938. https:\/\/doi.org\/10.1002\/art.37853 (2013).","journal-title":"Arthritis Rheum."},{"key":"90174_CR27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/ni1576","volume":"9","author":"A Yarilina","year":"2008","unstructured":"Yarilina, A., Park-Min, K. H., Antoniv, T., Hu, X. & Ivashkiv, L. B. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat. Immunol. 9, 378\u2013387. https:\/\/doi.org\/10.1038\/ni1576 (2008).","journal-title":"Nat. Immunol."},{"key":"90174_CR28","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560 (2018).","journal-title":"Bioinformatics"},{"key":"90174_CR29","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1093\/nar\/gkt660","volume":"41","author":"G Yaari","year":"2013","unstructured":"Yaari, G., Bolen, C. R., Thakar, J. & Kleinstein, S. H. Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations. Nucl. Acids Res. 41, e170. https:\/\/doi.org\/10.1093\/nar\/gkt660 (2013).","journal-title":"Nucl. Acids Res."},{"key":"90174_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004 (2015).","journal-title":"Cell Syst."},{"key":"90174_CR31","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.2106\/00004623-199809000-00005","volume":"80","author":"HG Potter","year":"1998","unstructured":"Potter, H. G., Linklater, J. M., Allen, A. A., Hannafin, J. A. & Haas, S. B. Magnetic resonance imaging of articular cartilage in the knee. An evaluation with use of fast-spin-echo imaging. J. Bone Joint Surg. Am. 80, 1276\u20131284. https:\/\/doi.org\/10.2106\/00004623-199809000-00005 (1998).","journal-title":"J. Bone Joint Surg. Am."},{"key":"90174_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.joca.2003.11.003","volume":"12","author":"CG Peterfy","year":"2004","unstructured":"Peterfy, C. G. et al. Whole-organ magnetic resonance imaging score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage 12, 177\u2013190. https:\/\/doi.org\/10.1016\/j.joca.2003.11.003 (2004).","journal-title":"Osteoarthritis Cartilage"},{"key":"90174_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14494","author":"P Singh","year":"2020","unstructured":"Singh, P., Lessard, S. G., Mukherjee, P., Rourke, B. & Otero, M. Changes in DNA methylation accompany changes in gene expression during chondrocyte hypertrophic differentiation in vitro. Ann. N. Y. Acad. Sci. https:\/\/doi.org\/10.1111\/nyas.14494 (2020).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"90174_CR34","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/jcp.22274","volume":"225","author":"P Bendinelli","year":"2010","unstructured":"Bendinelli, P. et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappaB inhibition via HGF. J. Cell Physiol. 225, 757\u2013766. https:\/\/doi.org\/10.1002\/jcp.22274 (2010).","journal-title":"J. Cell Physiol."},{"key":"90174_CR35","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1177\/0363546516637176","volume":"44","author":"JL Hudgens","year":"2016","unstructured":"Hudgens, J. L. et al. Platelet-rich plasma activates proinflammatory signaling pathways and induces oxidative stress in tendon fibroblasts. Am. J. Sports Med. 44, 1931\u20131940. https:\/\/doi.org\/10.1177\/0363546516637176 (2016).","journal-title":"Am. J. Sports Med."},{"key":"90174_CR36","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.3892\/mmr.2017.6365","volume":"15","author":"W Yin","year":"2017","unstructured":"Yin, W. et al. Comparative evaluation of the effects of plateletrich plasma formulations on extracellular matrix formation and the NFkappaB signaling pathway in human articular chondrocytes. Mol. Med. Rep. 15, 2940\u20132948. https:\/\/doi.org\/10.3892\/mmr.2017.6365 (2017).","journal-title":"Mol. Med. Rep."},{"key":"90174_CR37","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.4049\/jimmunol.158.7.3483","volume":"158","author":"H Moriuchi","year":"1997","unstructured":"Moriuchi, H., Moriuchi, M. & Fauci, A. S. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158, 3483\u20133491 (1997).","journal-title":"J. Immunol."},{"key":"90174_CR38","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl, H. L. Activators and target genes of Rel\/NF-kappaB transcription factors. Oncogene 18, 6853\u20136866. https:\/\/doi.org\/10.1038\/sj.onc.1203239 (1999).","journal-title":"Oncogene"},{"key":"90174_CR39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.arthro.2011.10.018","volume":"28","author":"SG Boswell","year":"2012","unstructured":"Boswell, S. G., Cole, B. J., Sundman, E. A., Karas, V. & Fortier, L. A. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy 28, 429\u2013439. https:\/\/doi.org\/10.1016\/j.arthro.2011.10.018 (2012).","journal-title":"Arthroscopy"},{"key":"90174_CR40","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/0363546515580787","volume":"44","author":"JC Riboh","year":"2016","unstructured":"Riboh, J. C., Saltzman, B. M., Yanke, A. B., Fortier, L. & Cole, B. J. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am. J. Sports Med. 44, 792\u2013800. https:\/\/doi.org\/10.1177\/0363546515580787 (2016).","journal-title":"Am. J. Sports Med."},{"key":"90174_CR41","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1177\/0363546515624678","volume":"44","author":"PA Smith","year":"2016","unstructured":"Smith, P. A. Intra-articular autologous conditioned plasma injections provide safe and efficacious treatment for knee osteoarthritis: an FDA-sanctioned, randomized, double-blind, placebo-controlled clinical trial. Am. J. Sports Med. 44, 884\u2013891. https:\/\/doi.org\/10.1177\/0363546515624678 (2016).","journal-title":"Am. J. Sports Med."},{"key":"90174_CR42","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/0363546512471299","volume":"41","author":"S Patel","year":"2013","unstructured":"Patel, S., Dhillon, M. S., Aggarwal, S., Marwaha, N. & Jain, A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am. J. Sports Med. 41, 356\u2013364. https:\/\/doi.org\/10.1177\/0363546512471299 (2013).","journal-title":"Am. J. Sports Med."},{"key":"90174_CR43","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00402-016-2545-2","volume":"136","author":"M Simental-Mendia","year":"2016","unstructured":"Simental-Mendia, M. et al. Leukocyte-poor platelet-rich plasma is more effective than the conventional therapy with acetaminophen for the treatment of early knee osteoarthritis. Arch. Orthop. Trauma Surg. 136, 1723\u20131732. https:\/\/doi.org\/10.1007\/s00402-016-2545-2 (2016).","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"90174_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13018-019-1203-0","volume":"14","author":"R Burchard","year":"2019","unstructured":"Burchard, R. et al. Efficiency of platelet-rich plasma therapy in knee osteoarthritis does not depend on level of cartilage damage. J. Orthop. Surg. Res. 14, 153. https:\/\/doi.org\/10.1186\/s13018-019-1203-0 (2019).","journal-title":"J. Orthop. Surg. Res."},{"key":"90174_CR45","doi-asserted-by":"publisher","first-page":"308","DOI":"10.2106\/JBJS.K.00430","volume":"94","author":"AD Mazzocca","year":"2012","unstructured":"Mazzocca, A. D. et al. Platelet-rich plasma differs according to preparation method and human variability. J. Bone Joint Surg. Am. 94, 308\u2013316. https:\/\/doi.org\/10.2106\/JBJS.K.00430 (2012).","journal-title":"J. Bone Joint Surg. Am."},{"key":"90174_CR46","doi-asserted-by":"publisher","first-page":"799","DOI":"10.7205\/MILMED-D-13-00336","volume":"179","author":"JR Evanson","year":"2014","unstructured":"Evanson, J. R. et al. Gender and age differences in growth factor concentrations from platelet-rich plasma in adults. Mil. Med. 179, 799\u2013805. https:\/\/doi.org\/10.7205\/MILMED-D-13-00336 (2014).","journal-title":"Mil. Med."},{"key":"90174_CR47","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/0363546517740845","volume":"46","author":"G Xiong","year":"2018","unstructured":"Xiong, G. et al. Men and women differ in the biochemical composition of platelet-rich plasma. Am. J. Sports Med. 46, 409\u2013419. https:\/\/doi.org\/10.1177\/0363546517740845 (2018).","journal-title":"Am. J. Sports Med."},{"key":"90174_CR48","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","volume":"20","author":"JT Barata","year":"2019","unstructured":"Barata, J. T., Durum, S. K. & Seddon, B. Flip the coin: IL-7 and IL-7R in health and disease. Nat. Immunol. 20, 1584\u20131593. https:\/\/doi.org\/10.1038\/s41590-019-0479-x (2019).","journal-title":"Nat. Immunol."},{"key":"90174_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0235-z","author":"SJ Kim","year":"2019","unstructured":"Kim, S. J. et al. Macrophages are the primary effector cells in IL-7-induced arthritis. Cell Mol. Immunol. https:\/\/doi.org\/10.1038\/s41423-019-0235-z (2019).","journal-title":"Cell Mol. Immunol."},{"key":"90174_CR50","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/art.30493","volume":"63","author":"SR Pickens","year":"2011","unstructured":"Pickens, S. R. et al. Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 63, 2884\u20132893. https:\/\/doi.org\/10.1002\/art.30493 (2011).","journal-title":"Arthritis Rheum."},{"key":"90174_CR51","first-page":"499","volume":"15","author":"E Heitzer","year":"2012","unstructured":"Heitzer, E. et al. IL-7, IL-18, MCP-1, MIP1-beta, and OPG as biomarkers for pain treatment response in patients with cancer. Pain Phys. 15, 499\u2013510 (2012).","journal-title":"Pain Phys."},{"key":"90174_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12891-016-1375-2","volume":"18","author":"JA Singh","year":"2017","unstructured":"Singh, J. A., Noorbaloochi, S. & Knutson, K. L. Cytokine and neuropeptide levels are associated with pain relief in patients with chronically painful total knee arthroplasty: a pilot study. BMC Musculoskelet. Disord. 18, 17. https:\/\/doi.org\/10.1186\/s12891-016-1375-2 (2017).","journal-title":"BMC Musculoskelet. Disord."},{"key":"90174_CR53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/JSA.0b013e3182999740","volume":"21","author":"GD Abrams","year":"2013","unstructured":"Abrams, G. D., Frank, R. M., Fortier, L. A. & Cole, B. J. Platelet-rich plasma for articular cartilage repair. Sports Med. Arthrosc. Rev. 21, 213\u2013219. https:\/\/doi.org\/10.1097\/JSA.0b013e3182999740 (2013).","journal-title":"Sports Med. Arthrosc. Rev."},{"key":"90174_CR54","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.3892\/etm.2018.6776","volume":"16","author":"S Ruan","year":"2018","unstructured":"Ruan, S., Deng, J., Yan, L. & Huang, W. Evaluation of the effects of the combination of BMP-2-modified BMSCs and PRP on cartilage defects. Exp. Ther. Med. 16, 4569\u20134577. https:\/\/doi.org\/10.3892\/etm.2018.6776 (2018).","journal-title":"Exp. Ther. Med."},{"key":"90174_CR55","doi-asserted-by":"publisher","first-page":"1463216","DOI":"10.1155\/2017\/1463216","volume":"2017","author":"B Linke","year":"2017","unstructured":"Linke, B. et al. Activated platelets induce an anti-inflammatory response of monocytes\/macrophages through cross-regulation of PGE2 and cytokines. Mediators Inflamm. 2017, 1463216. https:\/\/doi.org\/10.1155\/2017\/1463216 (2017).","journal-title":"Mediators Inflamm."},{"key":"90174_CR56","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1177\/0363546511419278","volume":"39","author":"GM van Buul","year":"2011","unstructured":"van Buul, G. M. et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am. J. Sports Med. 39, 2362\u20132370. https:\/\/doi.org\/10.1177\/0363546511419278 (2011).","journal-title":"Am. J. Sports Med."},{"key":"90174_CR57","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","volume":"20","author":"FJ Barrat","year":"2019","unstructured":"Barrat, F. J., Crow, M. K. & Ivashkiv, L. B. Interferon target-gene expression and epigenomic signatures in health and disease. Nat. Immunol. 20, 1574\u20131583. https:\/\/doi.org\/10.1038\/s41590-019-0466-2 (2019).","journal-title":"Nat. Immunol."},{"key":"90174_CR58","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.4049\/jimmunol.1800486","volume":"201","author":"AS Ahmed","year":"2018","unstructured":"Ahmed, A. S. et al. Activation of NF-kappaB in synovium versus cartilage from patients with advanced knee osteoarthritis: a potential contributor to inflammatory aspects of disease progression. J. Immunol. 201, 1918\u20131927. https:\/\/doi.org\/10.4049\/jimmunol.1800486 (2018).","journal-title":"J. Immunol."},{"key":"90174_CR59","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/138945010791011938","volume":"11","author":"KB Marcu","year":"2010","unstructured":"Marcu, K. B., Otero, M., Olivotto, E., Borzi, R. M. & Goldring, M. B. NF-kappaB signaling: multiple angles to target OA. Curr. Drug Targets 11, 599\u2013613. https:\/\/doi.org\/10.2174\/138945010791011938 (2010).","journal-title":"Curr. Drug Targets"},{"key":"90174_CR60","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bbi.2015.07.014","volume":"50","author":"JE Hartung","year":"2015","unstructured":"Hartung, J. E. et al. Nuclear factor-kappa B regulates pain and COMT expression in a rodent model of inflammation. Brain Behav. Immun. 50, 196\u2013202. https:\/\/doi.org\/10.1016\/j.bbi.2015.07.014 (2015).","journal-title":"Brain Behav. Immun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90174-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90174-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90174-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T11:13:41Z","timestamp":1699096421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90174-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90174"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90174-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"assertion":[{"value":"29 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11493"}}